Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives
Open Access
- 9 March 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5279
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most detrimental toxicity to a patient’s quality of life. Pathophysiological mechanisms involved in CIPN pathogenesis are complex, multifactorial, and only partially examined. They are suspected to be associated with oxidative stress (OS), mitochondrial dysfunction, ROS-induced apoptosis, myelin sheath and DNA damage, and immunological and inflammatory processes. Unfortunately, medications commonly used for the management of other neuropathic pain syndromes, including gabapentinoids, opioids, and tricyclic antidepressants (such as desipramine and nortriptyline), do not bring satisfactory results in CIPN. The aim of this review is to evaluate the existing literature on the potential use of medical ozone as a treatment for CIPN. This paper would explore the potential therapeutic benefits of medical ozone. The review would evaluate the existing literature on the use of medical ozone in other contexts, as well as its potential application in treating CIPN. The review would also suggest possible research methods, such as randomized controlled trials, to evaluate the efficacy of medical ozone as a treatment for CIPN. Medical ozone has been used to disinfect and treat diseases for over 150 years. The effectiveness of ozone in treating infections, wounds, and a variety of diseases has been well documented. Ozone therapy is also documented to inhibit the growth of human cancer cells and has antioxidative and anti-inflammatory effects. Due to its ability to modulate oxidative stress, inflammation, and ischemia/hypoxia, ozone may have a potentially valuable effect on CIPN.Keywords
This publication has 160 references indexed in Scilit:
- Effects of ozone applied by spinal endoscopy in patients with chronic pain related to failed back surgery syndrome: a pilot studyNeuropsychiatric Disease and Treatment, 2013
- Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathyRedox Biology, 2013
- Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA releasePain, 2011
- Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neuronsNeurobiology of Disease, 2011
- Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?Medical Gas Research, 2011
- Ozone therapy: A clinical reviewJournal of Natural Science, Biology and Medicine, 2011
- Transforming Growth Factor-β1 Impairs Neuropathic Pain through Pleiotropic EffectsMolecular Pain, 2009
- Setting up for the block: the mechanism underlying lidocaine's use‐dependent inhibition of sodium channelsThe Journal of Physiology, 2007
- Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growthEuropean Journal of Cancer, 2007
- Systemic Administration of Local Anesthetics to Relieve Neuropathic Pain: A Systematic Review and Meta-AnalysisAnesthesia & Analgesia, 2005